These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19816936)

  • 21. The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.
    Yamashita S; Tai P; Charron J; Ko C; Ascoli M
    Mol Endocrinol; 2011 Jul; 25(7):1211-22. PubMed ID: 21527500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
    Schramek H; Feifel E; Marschitz I; Golochtchapova N; Gstraunthaler G; Montesano R
    Am J Physiol Cell Physiol; 2003 Sep; 285(3):C652-61. PubMed ID: 12900389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
    Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G
    J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect.
    Aoidi R; Maltais A; Charron J
    Sci Signal; 2016 Jan; 9(412):ra9. PubMed ID: 26814233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
    Voisin L; Julien C; Duhamel S; Gopalbhai K; Claveau I; Saba-El-Leil MK; Rodrigue-Gervais IG; Gaboury L; Lamarre D; Basik M; Meloche S
    BMC Cancer; 2008 Nov; 8():337. PubMed ID: 19014680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK1/2 dual-specificity protein kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
    Roy M; Li Z; Sacks DB
    Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2.
    Bardwell AJ; Lagunes L; Zebarjedi R; Bardwell L
    J Biol Chem; 2017 May; 292(21):8750-8761. PubMed ID: 28396345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17.
    Kiga M; Tanzawa F; Iwasaki S; Inaba F; Fujiwara K; Iwadare H; Echigo T; Nakamura Y; Shibata T; Suzuki K; Yasumatsu I; Nakayama A; Sasazawa Y; Tashiro E; Imoto M; Kurakata S
    Anticancer Drugs; 2012 Jan; 23(1):119-30. PubMed ID: 22008853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
    Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition.
    Gilmartin AG; Bleam MR; Groy A; Moss KG; Minthorn EA; Kulkarni SG; Rominger CM; Erskine S; Fisher KE; Yang J; Zappacosta F; Annan R; Sutton D; Laquerre SG
    Clin Cancer Res; 2011 Mar; 17(5):989-1000. PubMed ID: 21245089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.
    Estes NR; Thottassery JV; Westbrook L; Kern FG
    Int J Oncol; 2006 Dec; 29(6):1573-80. PubMed ID: 17088999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2.
    Zhang H; Feng H; Luo L; Zhou Q; Luo Z; Peng Y
    Virus Res; 2010 Jun; 150(1-2):22-7. PubMed ID: 20172001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication.
    Zhu M; Duan H; Gao M; Zhang H; Peng Y
    Viruses; 2015 Mar; 7(3):1344-56. PubMed ID: 25803100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.
    Bae D; Ceryak S
    Biochem Biophys Res Commun; 2009 Aug; 385(4):523-7. PubMed ID: 19465001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor.
    Yeh TC; Marsh V; Bernat BA; Ballard J; Colwell H; Evans RJ; Parry J; Smith D; Brandhuber BJ; Gross S; Marlow A; Hurley B; Lyssikatos J; Lee PA; Winkler JD; Koch K; Wallace E
    Clin Cancer Res; 2007 Mar; 13(5):1576-83. PubMed ID: 17332304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin enhances growth hormone induction of the MEK/ERK signaling pathway.
    Xu J; Keeton AB; Franklin JL; Li X; Venable DY; Frank SJ; Messina JL
    J Biol Chem; 2006 Jan; 281(2):982-92. PubMed ID: 16272159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
    Guégan JP; Ezan F; Théret N; Langouët S; Baffet G
    Carcinogenesis; 2013 Jan; 34(1):38-47. PubMed ID: 23042098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.